EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Human milk glycosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor






Journal of Nutrition 125(3): 419-424

Human milk glycosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor

The binding of the HIV envelope glycoprotein, gp120, to its host cell receptor, CD4, is inhibited in a solid phase assay by a glycosaminoglycan of human milk; this binding is the essential first step in HIV infectivity. The human milk glycosaminoglycans were identified in this study. Pooled, fractionated human milk contained dermatan sulfate, heparin, heparan sulfate, and chondroitin sulfate. The ability of this glycosaminoglycan fraction to inhibit binding was unaffected by digestion with lytic enzymes specific for heparin, heparan sulfate and dermatan sulfate, but was lost when the milk fraction was treated with lytic enzymes specific for chondroitin sulfate. Furthermore, a purified milk fraction with high specific inhibitory activity contained chondroitin sulfate but not other glycosaminoglycans. This indicates that the ability of human milk to inhibit gp120 binding to CD4 may be attributed to chondroitin sulfate or to a chondroitin sulfate-like moiety rather than to other components of human milk. We speculate that this human milk glycosaminoglycan could limit the rate of postnatal vertical transmission of HIV in breast-fed infants of HIV-infected mothers.


Accession: 003162986

PMID: 7876916



Related references

Assays to detect AIDS receptor antagonists, compounds that inhibit the binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor in human T-lymphocytes. Abstracts of the General Meeting of the American Society for Microbiology 93(0): 436, 1993

Assays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor on human T lymphocytes. Antimicrobial Agents and ChemoTherapy 38(9): 2008-2013, 1994

Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells. Journal of Biological Chemistry 269(39): 24349-24353, 1994

Human milk glycosaminoglycan inhibits binding of the hiv glycoprotein gp 120 to its host receptor cd4. Pediatric Research 31(4 PART 2): 172A, 1992

CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5. Journal of Virology 77(1): 713-718, 2002

Hiv 1 glycoproteins gp120 and gp120 specifically inhibit the cd3 t cell antigen receptor phosphoinositide transduction pathway. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Fa78, 1990

Characterization of a human milk factor that inhibits binding of HIV GP120 to its CD4 receptor. Advances in Experimental Medicine and Biology 310: 281-291, 1991

Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120. Virology 329(2): 465-476, 2004

Inhibition of T cell receptor/CD3-mediated activation of p59-fyn and p56-lck by human immunodeficiency virus glycoprotein gp120. Journal of Immunology 150(8 PART 2): 101A, 1993

Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proceedings of the National Academy of Sciences of the United States of America 84(15): 5424-5428, 1987